Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients. - Wikidata - wikimedia - TriplyDB

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

http://www.wikidata.org/entity/Q30252749

about

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

http://www.wikidata.org/entity/Q30252749

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@ast

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@en

type

label

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@ast

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@en

prefLabel

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@ast

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.

@en

P1433

Q30252749-110420FD-D9EB-4A31-9F09-971A4A1F376F

P1476

Q30252749-ED78B92A-69F9-444D-A945-DA568A975A0A

P2093

Q30252749-1FDB6D6B-0E9E-4D6C-BF6F-64CA6C5A56A8

Q30252749-215B35ED-70C4-4270-9BD9-A958C4EE3E8C

Q30252749-5FCC3AE2-3769-4F99-8EA3-05B4B058C393

Q30252749-69947E0F-2D3E-408B-B51D-07E43D0F72E0

Q30252749-77ACDAE0-7A25-4132-81E7-0A9955776BF7

Q30252749-7E8ABDFB-D95D-4D4B-AF49-5779BA88028B

Q30252749-976D5822-1C9C-4748-97D7-B3950C3E3FE2

Q30252749-A49CAA17-E97B-4FBD-AB9C-60F3F932DF5A

Q30252749-A7B4EF22-797C-4372-AE30-ED91CE098316

Q30252749-A7F7D90B-83BB-46F8-A768-81824D50DA57

P2860

Q30252749-0F63ABC9-4688-445C-BCAD-62C9C1585237

Q30252749-15A396D7-8F18-40BA-84D9-A4889C6BB5A3

Q30252749-1CF597B5-E2C1-46E2-AE8A-88AEDDF8167C

Q30252749-1EB666BF-4D79-4AEA-9E6B-21A0462863BC

Q30252749-2FA16139-EA2B-416A-A5D0-64E7AFD83690

Q30252749-41EC98BA-603A-41F7-981A-D15FAD717064

Q30252749-487376F5-73BD-4021-8874-4A1556094BB2

Q30252749-4B89CA25-42BE-4CAF-A310-880B649D69C5

Q30252749-555D7421-8263-4C41-B7C5-102C89BFB2BD

Q30252749-5AAC38F3-6E5A-46B4-8679-7C452C5D9A42

P2888

Q30252749-366C9216-400E-4244-A0EB-429A772F38C4

P304

Q30252749-EDAD1033-A8BE-49F4-8DF4-492770EA7BE3

P31

Q30252749-608994C5-D3AD-41AF-A2E4-C67BC8E7204B

P356

Q30252749-7FEAC727-AF5E-42C6-BE27-57CE39E5B6AD

P433

Q30252749-6396B15B-F6DA-4342-9710-BCEDB0CA3472

P478

Q30252749-01D7C9F5-7629-4C98-B875-77B6833B08D0

P577

Q30252749-7C3B6AC9-CAA4-46BE-9C44-BA955AFAB798

P698

Q30252749-117420A5-E086-43A4-8DE7-248F29F61003

P932

Q30252749-D78FF7C7-7E2B-4E51-AC61-40B9DF9A93B4

P356

S00520-017-3670-3

P1433

Supportive Care in Cancer

P1476

Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients

@en

P2093

Abhinav Deol

http://www.w3.org/2001/XMLSchema#string

Dipenkumar Modi

http://www.w3.org/2001/XMLSchema#string

Divaya Bhutani

http://www.w3.org/2001/XMLSchema#string

Hyejeong Jang

http://www.w3.org/2001/XMLSchema#string

Joseph P Uberti

http://www.w3.org/2001/XMLSchema#string

Kamya Sankar

http://www.w3.org/2001/XMLSchema#string

Kendra Mellert

http://www.w3.org/2001/XMLSchema#string

Lawrence G Lum

http://www.w3.org/2001/XMLSchema#string

Lois Ayash

http://www.w3.org/2001/XMLSchema#string

Malini Surapaneni

http://www.w3.org/2001/XMLSchema#string

P2860

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas

Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance

Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis.

Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials.

Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America.

BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

P2888

s00520-017-3670-3

P304

2593-2601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-017-3670-3

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28365897

http://www.w3.org/2001/XMLSchema#string

P932

6886234

http://www.w3.org/2001/XMLSchema#string